2022

May 30 – June 3, 2022

Do you want to know more about BiomimX’s latest scientific advancement in developing human microphysiological systems? Join us in New Orleans at the MPS World Summit and learn directly from our Team about uKnee, uHeart and uScar models!

Explore

May 6, 2022 – ECTS

Save the date! Our collaborator OncoBone Ventures Limited is participating to the European Calcified Tissue Society Conference in Helsinki from May 6 to May 10, 2022. Don’t miss the chance to be updated on our uKnee model, presented by Tiina Kähkönen during the pre-congress session “Osteoarthritis and Bone” on May 6.

While also the startups that won the second edition of Cross The Bridge are taking the next steps in their projects, in this article StartupItalia recalls the four winners of the very first edition, including BiomimX.

We’re happy we took this opportunity !

Read here

4th Webinar on Wednesday, April 27, at 4 pm (GMT+2)

In this webinar our COO Roberta Visone is presenting uScar, a model of cardiac fibrosis developed by exploiting BiomimX® uStretch platforms and used in collaboration with Prof. Valeria Chiono from Politecnico di Torino to test advanced cardiac reprogramming therapeutics.

CEN-CENELEC Focus Group on Organ on Chip

On March 2nd, 2022 we participated to the Standards for Organ-on-Chip Focus Group Kick-off Meeting. We are excited to give our contribution in drafting standards in OoC!

The Focus Group shall ensure interaction between all relevant European stakeholders interested in potential standardization in the field of OoC. The Focus Group has been established by European standards organizations CEN and CENELEC with a secretariat by the Dutch organization for standards, NEN

We’re proud to be part of the The North American 3Rs Collaborative (NA3RsC) Microphysiological Systems (MPS) initiative.
The MPS initiative works together to increase industry adoption and regulatory acceptance of MPS technologies with the ultimate goal of refining, reducing, and replacing research animals.

Award

We are happy to share that our CEO, Paola Occhetta, has been selected among the 50 female entrepreneurs supported by the first call of the WomenTech EU program! Stay tuned to know how this exciting program will help us accelerating our vision!

We are glad to share our recently published review on Biophysical Reviews: “Current strategies of mechanical stimulation for maturation of cardiac microtissues”. 

Take a look

March 11, 2022

We are participating to CellToxDays 2022! Paola Occhetta, CEO of BiomimX, is presenting “Beating Organs-on-Chip: from single functional tissues to multiorgan models” on March 11th, at 10.40 AM (CET).

2021

December 7, 2021

Biofit 2021 is coming in few weeks, and we are ready!
Paola Occhetta is presenting BiomimX® Srl during the Startup Slams in the 3D culture session on Tuesday, December 7, at 11.30 CET.
Don’t miss this opportunity!

November 15-19

We are glad to partecipate to Termis World Congress 2021. Paola Occhetta, CEO of BiomimX, is presenting “3D in vitro models for drug screening and toxicology: experiences from the EU H2020 project SINERGIA and the EURION cluster”.

October 1, 10.00 am CEST

We’re glad to communicate that Paola Occhetta, BiomimX® Srl CEO, will present “Beating organs-on-chip as technological platforms in drug screening: advanced in vitro models of human physiology and pathology” at Centro 3R third Annual Convention, on October 1 at 10.00 am.
Save the date!

September 30, 2021

We’ll be at EIC Corporate Day with Merck!
We are already excited about possible future collaborations that may arise from this experience.
BiomimX® Srl will be represented by our CEO Paola Occhetta.

September 29 – October 1, 2021

We’ll be at the next Meet in Italy for Life Sciences 2021! Our CEO, Paola Occhetta, is representing BiomimX® Srl on September 29 – October 1. Don’t miss the opportunity to know more about our innovation and technology.

September 17, 2021 

Milano, 17/09/2021. Fidia Farmaceutici S.p.A. and BiomimX® Srl have signed a research collaboration agreement aimed at introducing and applying new Organs-on-Chip based technological solutions to the intra-articular medical device discovery process.

September 15, 14.30-15.30 CEST 

Save the date! Upcoming webinar on Wednesday 15th September, 14.30-15.30 CEST. Within the SINERGIA2020 framework we are glad to announce that Professor Bart Spee is going to present a webinar on Liver organoids for advanced in vitro models and whole organ engineering.

June 30, 2021 

Milano, 30th June 2021. Accelera – Part of NMS Group and BiomimX® Srl have signed a non-exclusive commercial agreement following an intense scientific collaboration aimed at introducing and applying new technological solutions to the drug discovery process.

June 10, 2021 3pm-4pm CEST

We are glad to announce that our CEO Paola Occhetta is presenting BiomimX® innovative solutions on the occasion of our win for the CrossTheBRIDGE2021.

June 16, 2021 4PM (GMT+2)

The second BiomimX Webinar is on its way, and we’re having a special guest this time! Together with Simona Marzorati, head of Laboratory at Accelera – Part of NMS Group , our COO Roberta Visone will present the potential of uHeart model throughout drug discovery and development. Don’t miss this! Register here

May 20, 2021

We are very pleased to announce that BiomimX® won first place in the 2021 Cross the Bridge competition called by Camera di Commercio Milano Monza Brianza Lodi, earning a 50.000 € prize to implement its project activities.

April 21, 2021

We are glad to announce that our CEO Paola Occhetta is participating to the Organ-on-a-Chip Symposia Series the 21st of April 2021.
She will talk about our human Osteoarthritic (OA) model uKnee and its potential as a tool for testing efficacy of anti-OA drugs and intra-articular medical devices.
Don’t miss it! Register now.

March 24, 2021 4PM (GMT+1)

Towards the replication of human complexity in vitro, we have developed uBeat® technology which allows to take the first steps to mimic human tissues behavior with an unprecedented precision.
Why not planning your next experimental campaign with something that could give you more flexibility and a better representation of clinical insights?
Learn more about uBeat® technology on our first free webinar.
Register here
 

February 9, 2021

We are glad to announce that our latest study “Micro-electrode channel guide (µECG) technology: an online method for continuous electrical recording in a human beating heart-on-chip” is now on-line on Biofabrication.
In this paper we present a new device capable of monitoring the electrical activity of beating cardiac microtissues, together with a proof-of-concept pharmacological validation.
This work is the result of a great collaboration between Academia (Politecnico di Milano) and Industries (BiomimX® Srl & Accelera Srl).
Read it here

January 21, 2021 (8 PM CET)

2020 has taught us how crucial is to invest in Research, mostly to reduce technical time for testing drugs and medical devices.
Paola Occhetta, BiomimX CEO, and Marco Rasponi, BiomimX President, will explain how our startup contributes to bring pharmaceutical companies to the market with more efficient therapies in a shorter time, thanks to our innovative technologies.
Don’t miss the episode of STARTUPPER broadcast on Thursday 21st January starting at 8 PM CET on channel 821 Sky.

January 20, 2021 (2.30-3.30 PM CET)

Upcoming webinar! Within the SINERGIA framework we are glad to announce that professor Paul Bourgine will be the first speaker of our webinars series, invited by BiomimX® Srl. Prof. Bourgine’s laboratory targets the development of miniaturized human bone organs (hOssicles) in mice to be used as advanced model of healthy and malignant human hematopoiesis. This talk will first cover how embryonic processes can be harnessed for the engineering of hOssicles. The advantages of the hOssicle approach as opposed to standard in vitro and in vivo models will be discussed.
Take a look!

2020

December 7th-10th , 2020

BiomimX® will partecipate to the Digital Biofit 2020 from December 7th to December 10th 2020. We are looking forward to virtually meet you during the one-to-one partnering event and to take part to this exiting Life Science fair!
Take a look!

August, 2020

The Results in Brief Article of the uHeart Project, a collaborative effort of BiomimX® and CORDIS, has been published on the CORDIS website in six different languages.
Take a look!

July 29th, 2020

We are glad to announce that today our company name, BiomimX®, and our technology name, uBeat®, have both received the trademark registration.

July, 2020

Check the newly elected Members of the European Organ-on-Chip Society (EUROoCS) Executive Board. Congratulation Marco Rasponi!

 

July, 2020

BiomimX® S.r.l. will participate to the online European Organ-on-Chip Society (EUROoCs) annual meeting 2020 on 8 and 9 July 2020

May, 2020

BiomimX® S.r.l. and NeuroZone S.r.l.  signed a strategic commercial partnership for uKnee services

Check it here!

April, 2020

Stefano Piazza, Roberta Visone from BiomimX S.r.l., Simona Marzorati from Accelera and Erika Ferrari from Politecnico di Milano joined the #EUvsVIRUS hackaton, conceiving tha “BeatingCovidOnChip”, an innovative microfluidic platform to speed up the drug screening process for Covid-19 treatments.
#BeatMyCovid to #BeatThemAll!

March, 2020

Our CEO Paola Occhetta at the microphone of #Radio24 to discuss about the future goals of BiomimX®

Thanks Maurizio Melis and #SmartCity for the opportunity!

Check it here!

March, 2020

BiomimX® Srl is one of the 5 Top Lab-On-A-Chip Startups impacting Engineering according to StartUs Insights!

Check it here!

February, 2020

BiomimX® Srl winner of the prize #DigitalForHealth. Thanks to Consorzio DAFNE for the opportunity!

2019

October, 2019

BiomimX® obtains the SME Instrument phase 1

Thanks to the SME Instrument Phase 1awarded for the project uHeart, BiomimX® will accelerate its way to the market!

October, 2019

BiomimX® will partecipate to the EUSAAT Congress, the 22nd European Congress on  Alternatives to Animal Testing  organized in Linz

September, 2019

Best poster award at the Safety Pharmacology Society 2019 Annual Meeting

In a collaborative project of BiomimX®, Politecnico di Milano and Accelera S.r.l., Roberta Visone was awarded the first place in the 2019 Jr. Investigator Poster Contest at the Safety Pharmacology Society 2019 Annual Meeting. September 23-26, 2019, Barcelona, Spain.

Visone R, Marzorati S, Perego V, Occhetta P, Pesenti E,Rasponi M. “uHeart: a beating heart-on-chip platform for on-line recording of functional 3D cardiac microtissues’ electrical activity”

Contratulations Roberta!

June, 2019

SINERGIA project (MSCA-ITN-ETN-2019) was financed by EU Commission

BiomimX® is part of the SINERGIA network. SINERGIA aims to provide breakthrough strategies for the implementation of new in vitro preclinical platforms in terms of innovative technologies, biological models and drug screening approaches in the effort of bridging the gap between current, simplistic in vitro cultures and faithful and effective future physiological models. More info here!

June, 2019

BiomimX® receives its third Seal of Excellence H2020 from the European Commission!

2018

November, 2018

BiomimX® won the 3rd prize at the “EIT Joint Grand Final” in Budapest

On 16th November 201, BiomimX® was awarded the third prize in  the competition HeadStart Funding, which was created to accelerate products and solutions in SMEs and bring the companies to an investment-ready stage.

November, 2018

BiomimX® receives a new Seal of Excellence H2020 from the European Commission

September, 2018

BiomimX® was awarded the First Prize at the Business Plan Competition at TERMIS 2018!

BiomimX® was awarded the First Prize in the Business Plan Competition in Kyoto, during the 5th World Congress of the Tissue Engineering and Regenerative Medicine International Society (Kyoto, Japan).

June, 2018

BiomimX® in Naples for the European Health Catapult and Headstart regional selection event

BiomimX® participated to the final selection, and it was voted as one of the best 8 Teams in the Headstart program. Besides being awarded a prize money (€35,000), our Team will have the possibility to mature its business plan, negotiation and pitching skills as well as to learn from experts thanks to EIT.

April, 2018

BiomimX® at Lab on a chip Symposium in Basel

BiomimX® will participate to the Lab on a chip Symposium – from molecular assays to organs on a chip organized in Basel by The Royal Society of Chemistry journal Lab on a Chip and ETH Zurich.

April, 2018

BiomimX® receives its first Seal of Excellence H2020 from the European Commission
 

March, 2018

BiomimX® at Bootcamp of BioInItaly/StartUp Initiative 2018 by Intesa Sanpaolo

BiomimX® has been selected and invited to the training and selection phase of the BioInItaly/StartUp Initiative 2018, in the Biotech track. Intesa Sanpaolo Start-Up Initiative is a comprehensive program aimed at technology start-ups looking for concrete business opportunities: every few months, a rigorous selection and training process leads the best start-ups to high-profile, technology-specific events called Arena Meetings, where they can pitch to international investors and corporations.

2017

November, 2017

SNSF/Innosuisse BRIDGE PoC grant for Knee-on-chip

Paola Occhetta was awarded the SNSF/CIT BRIDGE Proof-of-Concept grant for developing a Knee-on-chip platform to speed up the research for anti-osteoarthritic drugs. She will receive 130,000 Swiss francs in funding to implement her project within a collaboration between University Hospital of Basel and BiomimX®.

November, 2017

BiomimX® at Bioindustry Park thanks to Premio Marzotto

BiomimX® has classified among the 10 finalists of Premio Marzotto 2017 – Dall’idea all’impresa with its uKnee model. With its idea, BiomimX® was awarded with one year of mentoring and incubation at Bioindustry Park, a startup incubator located in Ivrea (Italy). Bioindustry Park, lead by Silvano Fumero, is the ideal location and solution to companies in need of efficiency, quality and image.

May, 2017

BiomimX® was founded after winning StartCup Lombardia 2016, in the category of Life Science & Agrofood with its uBeat® technology.

2016

April, 2016

BiomimX® among 10 finalists of Bioupper 2015

BiomimX® has classified among the 10 finalists of the first edition of Bioupper – Let’s give life to life Startups, the empowerment acceleration program for LifeTech startups organized by Novartis and Fondazione Cariplo.